Cargando…

Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is currently the most prevalent chronic liver disease in Western countries, affecting approximately 25% of the adult population. This condition encompasses a spectrum of liver diseases characterized by abnormal accumulation of fat in liver tissue (non-alcoho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marques, Patrice, Francisco, Vera, Martínez-Arenas, Laura, Carvalho-Gomes, Ângela, Domingo, Elena, Piqueras, Laura, Berenguer, Marina, Sanz, Maria-Jesus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916753/ https://www.ncbi.nlm.nih.gov/pubmed/36768637 http://dx.doi.org/10.3390/ijms24032313

Ejemplares similares

An updated overview of e-cigarette impact on human health
por: Marques, Patrice, et al.
Publicado: (2021)

Oral Unsaturated Fat Load Impairs Postprandial Systemic Inflammation in Primary Hypercholesterolemia Patients
por: Collado, Aida, et al.
Publicado: (2021)

Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
por: Francisco, Vera, et al.
Publicado: (2022)

Systemic Inflammation in Metabolic Syndrome: Increased Platelet and Leukocyte Activation, and Key Role of CX(3)CL1/CX(3)CR1 and CCL2/CCR2 Axes in Arterial Platelet-Proinflammatory Monocyte Adhesion
por: Marques, Patrice, et al.
Publicado: (2019)

Novel Immune Features of the Systemic Inflammation Associated with Primary Hypercholesterolemia: Changes in Cytokine/Chemokine Profile, Increased Platelet and Leukocyte Activation
por: Collado, Aida, et al.
Publicado: (2018)

Cigarette Smoke Increases Endothelial CXCL16-Leukocyte CXCR6 Adhesion In Vitro and In Vivo. Potential Consequences in Chronic Obstructive Pulmonary Disease
por: Marques, Patrice, et al.
Publicado: (2017)

An Overview of the Mechanism of Penthorum chinense Pursh on Alcoholic Fatty Liver
por: Zhao, Xingtao, et al.
Publicado: (2020)

The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors
por: Palano, Maria Teresa, et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Understanding the cellular interactome of non-alcoholic fatty liver disease
por: Wallace, Sebastian J., et al.
Publicado: (2022)

Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
por: Robea, Madalina Andreea, et al.
Publicado: (2023)

Role of Soluble Adiponectin Receptor 2 in Non-Alcoholic Fatty Liver Disease in Children
por: Aksoy, Gulsah Kaya, et al.
Publicado: (2019)

The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease
por: Engelmann, Cornelius, et al.
Publicado: (2022)

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease
por: Perumpail, Brandon J., et al.
Publicado: (2017)

Water Soluble Vitamin E Administration in Wistar Rats with Non-alcoholic Fatty Liver Disease
por: Tzanetakou, Irene P, et al.
Publicado: (2012)

CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction
por: Hueso, Luisa, et al.
Publicado: (2023)

Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
por: de Carvalho, Sylene Coutinho Rampche, et al.
Publicado: (2013)

The Collaborative Study on the Genetics of Alcoholism: Overview
por: Agrawal, Arpana, et al.
Publicado: (2023)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Alcoholism and the Brain: An Overview
por: Oscar-Berman, Marlene, et al.
Publicado: (2003)

Presence of Fatty Liver and the Relationship between Alcohol Consumption and Markers of Inflammation
por: Kächele, Martin, et al.
Publicado: (2015)

Spatial molecular and cellular determinants of STAT3 activation in liver fibrosis progression in non-alcoholic fatty liver disease
por: Jiao, Jingjing, et al.
Publicado: (2022)

Omega Fatty Acids and Inflammatory Bowel Diseases: An Overview
por: Marton, Ledyane Taynara, et al.
Publicado: (2019)

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
por: Malnick, Stephen D. H., et al.
Publicado: (2022)

Fetal Alcohol Spectrum Disorders: An Overview from the Glia Perspective
por: Wilhelm, Clare J., et al.
Publicado: (2016)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
por: Saltzman, Emma T., et al.
Publicado: (2018)

Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease
por: Katsarou, Angeliki, et al.
Publicado: (2020)

Liver macrophages and inflammation in physiology and physiopathology of non‐alcoholic fatty liver disease
por: Thibaut, Ronan, et al.
Publicado: (2021)

Early-stage non-alcoholic fatty liver disease in relation to atherosclerosis and inflammation
por: Tan, Si-hua, et al.
Publicado: (2023)

Soluble proteins of chemical communication: an overview across arthropods
por: Pelosi, Paolo, et al.
Publicado: (2014)

The soluble guanylate cyclase stimulator IW‐1973 prevents inflammation and fibrosis in experimental non‐alcoholic steatohepatitis
por: Flores‐Costa, Roger, et al.
Publicado: (2018)

Effect of over the counter mouthwashes with and without alcohol on sorption and solubility of bulk fill resins
por: Prado, Vera, et al.
Publicado: (2020)

Murine Models for the Study of Fetal Alcohol Spectrum Disorders: An Overview
por: Almeida, Laura, et al.
Publicado: (2020)

Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy
por: Wan, Shuqian, et al.
Publicado: (2018)

Physicochemical properties of superfine grinding-microwave modified artichoke soluble dietary fiber and their alleviation of alcoholic fatty liver in mice
por: Wang, Yayi, et al.
Publicado: (2023)

Validation of an Online Version of the Alcohol Use Disorders Identification Test (AUDIT) for Alcohol Screening in Spanish University Students
por: Ballester, Laura, et al.
Publicado: (2021)

An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
por: Silva Figueiredo, Priscila, et al.
Publicado: (2018)

Overview of studies of the vitamin D/vitamin D receptor system in the development of non-alcoholic fatty liver disease
por: Cimini, Flavia Agata, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_i1udu02sgg194rmkve4accb3ca